Management changes at Elsevier and RBI Netherlands

Arie Jongejan decides to leave position at Elsevier as CEO, Science & Technology; Herman van Campenhout announced as successor.

Amsterdam, 13 December 2004 – Erik Engstrom, Chief Executive Officer of Elsevier, and Gerard van de Aast, CEO of Reed Business, have announced management changes. 

Arie Jongejan, the current CEO of Elsevier’s Science & Technology division, has decided to leave the company at the end of the year to pursue new interests. Mr. Jongejan is recognised as one of the leaders in scientific publishing. His achievements include the development of a wide range of publishing programmes and key involvement in the creation and development of, amongst others, ScienceDirect and Scopus. Mr. Jongejan is a member of the executive councils of the Publishers’ Association (UK) and the International Association of Scientific, Technical and Medical Publishers.

“I am very grateful to Arie for his contribution to Elsevier over the past 24 years and wish him every success for his future plans,” said Erik Engstrom.

Herman van Campenhout will join Elsevier as CEO, Science & Technology on 1 January 2005 from Reed Business Information (RBI) in the Netherlands, where he has been CEO since 2001. 

Before joining RBI, Mr. van Campenhout spent 17 years in the Royal Dutch Shell Group, where he held several management positions around the globe, serving in Central and South America and Europe. His last position at Shell was Board Director, Shell Netherlands. Mr. van Campenhout is a Dutch national, is married and has two children.

Engstrom said, “I am delighted to have Herman join Elsevier. His knowledge of the publishing industry, combined with Elsevier’s existing, strong Science & Technology management team will certainly provide a smooth, timely and effective transition.“

Mr. Van Campenhout’s position at RBI Netherlands will be filled by Marianne van Leeuwen, currently a director in the Boston division of RBI USA. Ms. van Leeuwen has worked for the company for 17 years, holding senior positions in the Netherlands, France and the USA.


About Reed Business Information NL
Reed Business Information NL (RBI NL) is a leading European business-to-business publisher. It provides up-to-date information to its target markets in the areas of management, retail, agriculture and horticulture, logistics, food, service provision, care, public administration, engineering, recreation and health care. RBI NL also publishes information for professionals in the legal field and in construction, human resources, automotive, travel, catering, finance, welfare and education.

About Reed Elsevier Group plc
Reed Elsevier Group plc is a world leading publisher and information provider. It is owned equally by its two parent companies, Reed Elsevier PLC and Reed Elsevier NV. The parent companies are listed on the London, Amsterdam and New York Stock Exchanges, under the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL. In 2003, Reed Elsevier made adjusted profit before taxation of £1,010 million on turnover of £4,925 million. The group employs 35,000 people, including approximately 22,000 in North America. Operating in the scientific, legal, educational and business-to-business sectors, Reed Elsevier provides high value and flexible information solutions to professional end users, with increasing emphasis on internet delivery.

About Elsevier
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers.